LncRNA MELTF-AS1 promotes colorectal cancer progression via the miR-139-5p/NOTCH1 ceRNA axis
Medical Oncology · 14.11.2026 · 43 (12)
DOI: 10.1007/s12032-026-03475-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 14.11.2026. Verfasst von Wen Chang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Surgery 1, HuBei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.116, Zhuodaoquan South R…. Hauptthemen laut MEDLINE: MicroRNAs, Receptor, Notch1, Colorectal Neoplasms, RNA, Long Noncoding. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
To investigate the expression, clinical significance, and underlying molecular mechanism of lncRNA MELTF-AS1 in colorectal cancer (CRC). MELTF-AS1 expression and its prognostic value in CRC were preliminarily analyzed using the UALCAN database. RT-qPCR validated MELTF-AS1 expression in 112 matched tumor-normal tissue pairs and CRC cell lines, with Kaplan–Meier analysis confirming its prognostic role. CCK-8, flow cytometry, and Transwell assays assessed how MELTF-AS1 silencing could alter malignant CRC cell phenotypes. Subcellular localization assay, dual-luciferase reporter assay, and rescue experiments were conducted to explore the regulatory relationship among MELTF-AS1, miR-139-5p, and NOTCH1, and clarify the underlying molecular mechanism. MELTF-AS1 exhibited elevated expression in CRC tissues and cell lines (P < 0.0001), with high MELTF‑AS1 expression representing an independent prognostic risk factor for poor overall survival in CRC patients (HR = 2.606, 95%CI: 1.159–5.860, P = 0.020). MELTF-AS1 knockdown inhibited the proliferation, migration, and invasion of CRC cells, while facilitating cell apoptosis. Mechanistically, cytoplasmic MELTF-AS1 functioned as a ceRNA by sponging miR-139-5p. A significant negative correlation between MELTF‑AS1 and miR‑139‑5p was observed in clinical CRC tissues (r = − 0.771, P < 0.0001), which upregulated NOTCH1 expression accordingly. MELTF-AS1 promotes CRC progression through the MELTF-AS1/miR-139-5p/NOTCH1 axis, indicating it as a potential prognostic biomarker and therapeutic target for CRC, with subtype‑specific prognostic performance indicated by public databases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Surgery 1, HuBei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.116, Zhuodaoquan South Road, Hongshan District, Hubei, 430079, China.
- Hubei Provincial/Wuhan Clinical Research Center for Colorectal Cancer, Hubei, 430079, China.
- Gastrointestinal Surgery 1, HuBei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.116, Zhuodaoquan South Road, Hongshan District, Hubei, 430079, China. wumingyuewh027@163.com.
- Hubei Provincial/Wuhan Clinical Research Center for Colorectal Cancer, Hubei, 430079, China. wumingyuewh027@163.com.
Zitieren
APA
Chang, W., & Wu, M. (2026). LncRNA MELTF-AS1 promotes colorectal cancer progression via the miR-139-5p/NOTCH1 ceRNA axis. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03475-4
Vancouver
Chang W, Wu M. LncRNA MELTF-AS1 promotes colorectal cancer progression via the miR-139-5p/NOTCH1 ceRNA axis. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03475-4
BibTeX
@article{Chang2026,
author = {Chang, Wen and Wu, Mingyue},
title = {LncRNA MELTF-AS1 promotes colorectal cancer progression via the miR-139-5p/NOTCH1 ceRNA axis},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {12},
doi = {10.1007/s12032-026-03475-4}
}
EUVIMED